Novavax (NASDAQ: NVAX)
Novavax Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Novavax Company Info
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
News & Analysis
Better Buy: Inovio Pharmaceuticals vs. Novavax
Both biotechs have been struggling for a while, but there might be some hope for them.
3 Things You Need to Know If You Buy Novavax Today
The vaccine maker's recovery story is looking brighter.
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
The biotech still hasn't lost momentum.
Is Novavax Stock a Buy?
Can Novavax's stock continue soaring?
Could Novavax Become the Next Moderna?
Sanofi believes in Novavax's vaccine strengths...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
This coronavirus vaccine maker entered the market behind rivals.
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
A potentially very lucrative arrangement with a peer doesn't necessarily make the company a buy.
Valuation
Earnings Transcripts
Novavax Inc (NVAX) Q3 2021 Earnings Call Transcript
NVAX earnings call for the period ending September 30, 2021.
Novavax (NVAX) Q1 2020 Earnings Call Transcript
NVAX earnings call for the period ending March 31, 2020.
Novavax Inc (NVAX) Q2 2019 Earnings Call Transcript
NVAX earnings call for the period ending June 30, 2019.
Novavax Inc (NVAX) Q1 2019 Earnings Call Transcript
NVAX earnings call for the period ending March 31, 2019.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.